Recent advances in the production of recombinant factor IX: bioprocessing and cell engineering
Sign Up to like & getrecommendations! Published in 2022 at "Critical Reviews in Biotechnology"
DOI: 10.1080/07388551.2022.2036691
Abstract: Abstract Appropriate treatment of Hemophilia B is vital for patients’ quality of life. Historically, the treatment used was the administration of coagulation Factor IX derived from human plasma. Advancements in recombinant technologies allowed Factor IX… read more here.
Keywords: recombinant factor; bioprocessing cell; factor; production ... See more keywords